Conferences - Results from #180

AUA 2022: Evaluating the Quality of Social Media Content on Urolithiasis Procedures May 14, 2022

AUA 2022: Management of Incidentally Discovered 3cm Solid Renal Mass Cancer: Panel Discussion May 14, 2022

AUA 2022: Accuracy and Racial/Ethnic Representation of Prostate Cancer Screening Videos on Youtube and Tiktok May 14, 2022

AUA 2022: Is A Restaging TURBT Necessary in High Risk NMIBC if the Initial TURBT Was Performed Using Blue Light? May 13, 2022

AUA 2022: Long-term Follow-up of Intravesical Gemcitabine and Docetaxel as Rescue Therapy for NMIBC May 13, 2022

AUA 2022: Prognostic Model of Upfront Cytoreductive Nephrectomy in Patients with Metastatic RCC Treated with Immune-Checkpoint Inhibitors And/or Tyrosine Kinase Inhibitors May 13, 2022

AUA 2022: Survival After Radical Prostatectomy Versus Radiation Therapy in Ductal Carcinoma of the Prostate May 13, 2022

AUA 2022: Impact of Disease Status Heterogeneity of the STAMPEDE Trial Arm J Population on Oncological Outcomes in High-Risk Nonmetastatic Prostate Cancer May 13, 2022

AUA 2022: Topographic Description of the Site of Positive mpMRI and Impact on the Risk of Positive Surgical Margins at Robot-Assisted Nerve Sparing Radical Prostatectomy: Implications for Accurate Surgical Approaches May 13, 2022

AUA 2022: Immune-Related Adverse Events Associated with Better Survival Outcomes for Metastatic Renal Cell Carcinoma Treated with Nivolumab + Ipilimumab May 13, 2022

AUA 2022: Oncologic Outcomes in Patients Diagnosed with pT3aN0M0 Renal Cell Cancer According to Renal Vein Thrombus or Fat Invasion May 13, 2022

AUA 2022: Outcomes of Nephrectomy for Renal Cell Carcinoma with Venous Thrombus Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study May 13, 2022

AUA 2022: Women in Urologic Oncology: Past, Present, and Future May 13, 2022

AUA 2022: Prospective Evaluation of ctDNA in Detecting Early Progression on Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Cancers May 13, 2022

AUA 2022: Survivor Debate: NMIBC Refractory BCG: Cystectomy, Systemic Immunotherapy, Intravesical Chemotherapy May 13, 2022

AUA 2022: Impact of 18F-RHPSMA-7.3 PET on Upstaging of Patients with Prostate Cancer Recurrence: Results from the Prospective, Phase 3, Multicenter, SPOTLIGHT Study May 13, 2022

AUA 2022: Final Clinical Results of Pivotal Trial of IL-15R&[alpha]Fc Superagonist N-803 with BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) CIS and Papillary Cohorts May 13, 2022

Studies Debunk COVID-19 Fertility & Transplant Concerns; Long-term Impact of COVID Yet to be Realized in Prostate & Bladder Cancer Patients May 13, 2022

AUA 2022: State-of-the-Art Lecture: PSMA Diagnostics and Theranostics May 13, 2022

AUA 2022: Primary Versus Secondary Muscle Invasive Bladder Cancer: Comparing the Pathologic and Oncologic Outcomes Between Both Forms of Muscle Invasive Disease When Treated with Standard of Care May 13, 2022

Page 10 of 465

email news signup